Feb 15 (Reuters) - Peter Steinberger, the founder of OpenClaw, is joining OpenAI, and the open-source bot is becoming a foundation, OpenAI CEO Sam Altman said on Sunday. "Peter Steinberger is joining ...
From small publishers to US federal agencies, websites are reporting unusual spikes in automated traffic linked to IP addresses in Lanzhou, China. When he first noticed the traffic spike, Quintero ...
Stephen Hemsley, leader of giant UnitedHealth Group, for years has made private investments in healthcare startups, including firms that do business with—or compete against—UnitedHealth. The ...
LONDON, Feb 6 (Reuters) - Singer Elton John told London's High Court on Friday he was incensed to learn of allegations his landline phones had been bugged on behalf of the Daily Mail, saying the ...
Asking a female colleague if they are going through the menopause is not 'inherently offensive' and does not amount to harassment, an employment tribunal has ruled. The ruling comes in a new judgement ...
The boss of Britain’s biggest defence company has called for ‘clarity’ over the government’s military spending plans amid a blazing row over budgets. BAE Systems chief Charles Woodburn said the ...
It is one of the biggest questions in modern dating – how soon is too soon to get in touch after the first date? Luckily a scientific study can now provide an answer. If you really like someone, send ...
When the century began, golf course design and development were in a very different place. Hundreds of new courses were opening annually, including dozens of stand-alone, upscale daily-fee facilities ...
I’m not above doing some gig work to make ends meet. In my life, I’ve worked snack food pop-ups in a grocery store, ran the cash register for random merch booths, and even hawked my own plasma at $35 ...
This chilling prospect has become reality within Moltbook, an experimental social network built exclusively for AI agents, where a collective of bots has rapidly formed a self-governing “underground” ...
YARAL Pharma Inc. (YARAL Pharma), the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland, today announced that its ...
The conversion of two-dimensional visual references into three-dimensional digital assets has historically required specialized modeling expertise and significant time allocation. Hyper3D, the ...